Oncolytic Virus OH2 Induces PD-L1 Upregulation via NF-κB Signaling and Synergizes with Anti-PD-L1 Therapy in Prostate Cancer through a Targeted Extracellular Vesicle Delivery System

By
Emily Salmini
-
0
20
Scientists evaluated the antitumor effects of the oncolytic virus oncolytic herpes simplex virus type 2 (OH2) in prostate cancer cell lines and mouse models.
[Journal for Immunotherapy of Cancer]
Full Article